+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastroenterology Market - Global Forecast Report 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895144
The global gastroenterology market was valued USD 46.7 billion in 2023, driven by the rising incidence of gastrointestinal disorders, aging population, advancements in technology has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 5.1% during the forecast period of 2024-2032 to achieve a value of USD 72.9 billion by 2032.

Gastroenterology: Introduction

Gastroenterology is a specialized field of medicine focused on the diagnosis, treatment, and management of disorders related to the digestive system, which includes the esophagus, stomach, small intestine, large intestine, liver, gallbladder, pancreas, and rectum. Gastroenterologists are the medical professionals trained to treat conditions like gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel diseases like Crohn's and ulcerative colitis, liver diseases like hepatitis, and gastrointestinal cancers among other conditions.

Importance in Global Healthcare: With the increase in lifestyle-related disorders, aging populations, and growing awareness about gastrointestinal health, gastroenterology has become an essential component of global healthcare. Digestive disorders are among the leading causes of doctor visits, hospitalizations, and disability worldwide.

Key Trends in the Global Gastroenterology Market

  • Increasing Prevalence of GI Disorders: There's a rising global incidence of gastroenterological disorders such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS), which is driving demand for both diagnostic and therapeutic interventions.
  • Advances in Endoscopy: Developments in endoscopic techniques, like capsule endoscopy and endoscopic ultrasound, offer less invasive diagnostic and therapeutic options, improving patient comfort and clinical outcomes.
  • Personalized Medicine: Tailoring treatment based on individual patient genetics or specific disease phenotypes, especially in conditions like IBD, is becoming more common. This approach can improve treatment efficacy and reduce side effects.
  • Growth of Biologics: The introduction and acceptance of biologics, such as anti-TNF agents, to treat conditions like IBD has revolutionized patient outcomes. The development of newer agents targeting different pathways continues to be a trend.
  • Microbiome Research: The gut microbiome, the diverse community of microorganisms residing in the digestive tract, is now recognized as a pivotal factor in gastroenterological health and disease. Therapies targeting the microbiome, including fecal microbiota transplants and probiotics, are gaining traction.

Global Gastroenterology Market Segmentation

The market can be categorised into product type, indications, end user and region.

Market Breakup by Product Type

Drugs

  • Proton Pump Inhibitor
  • H2 Antihistamine
  • Others

Medical Devices

  • Endoscopy Devices
  • Therapeutic devices
  • Others
  • Diagnostic Tools
  • Others

Market Breakup by Indications

  • Inflammatory Bowel Disease (IBD)
  • Gastroesophageal Reflux Disease (GERD)
  • Colorectal Cancer
  • Liver Diseases
  • Pancreatic Disorders
  • Others

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Gastroenterology Market Overview

The global gastroenterology market represents a significant segment within the healthcare sector, focusing on the diagnosis, treatment, and management of digestive system disorders. These encompass conditions affecting the oesophagus, stomach, small intestine, large intestine (colon), liver, gallbladder, and pancreas. The market usually comprises a mix of large multinational corporations and smaller specialized companies. Mergers, acquisitions, and collaborations are common strategies for growth and expansion.

Regional overview:

North America: Widely recognized as a leading market, fueled by a sophisticated healthcare ecosystem, heightened public awareness, and easy access to cutting-edge treatments.

Europe: Comparable to North America in many respects but distinguishes itself through the variety of healthcare models across its different nations.

Asia Pacific: A burgeoning market characterized by its rapidly expanding healthcare facilities and growing public consciousness about gastrointestinal disorders.

Rest of the World: Comprising areas such as Latin America, the Middle East, and Africa, these markets are in the nascent stages of developing their healthcare infrastructure.

Key Players in the Global Gastroenterology Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in global gastroenterology market are as follows:

  • Abbott Laboratories
  • Johnson & Johnson
  • AbbVie Inc.
  • Salix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • ALLERGAN
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Astellas Pharma US, Inc.
  • Pfizer Inc.
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Gastroenterology Market Overview
3.1 Global Gastroenterology Market Historical Value (2017-2023)
3.2 Global Gastroenterology Market Forecast Value (2024-2032)
4 Global Gastroenterology Market Landscape
4.1 Global Gastroenterology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Gastroenterology Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Applications
5 Global Gastroenterology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Gastroenterology Market Segmentation
6.1 Global Gastroenterology Market by Product Type
6.1.1 Market Overview
6.1.2 Drugs
6.1.2.1 Proton Pump Inhibitor
6.1.2.2 H2 Antihistamine
6.1.2.3 Others
6.1.3 Medical Devices
6.1.3.1 Endoscopy Devices
6.1.3.2 Therapeutic devices
6.1.3.3 Others
6.1.4 Diagnostic Tools
6.1.5 Others
6.2 Global Gastroenterology Market by Indications
6.2.1 Market Overview
6.2.2 Inflammatory Bowel Disease (IBD)
6.2.3 Gastroesophageal Reflux Disease (GERD)
6.2.4 Colorectal Cancer
6.2.5 Liver Diseases
6.2.6 Pancreatic Disorders
6.2.7 Others
6.3 Global Gastroenterology Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Specialty Clinics
6.3.5 Research Institutes
6.3.6 Others
6.4 Global Gastroenterology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Gastroenterology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Gastroenterology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Gastroenterology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Gastroenterology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Gastroenterology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Johnson & Johnson
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 AbbVie Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Salix Pharmaceuticals
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 GlaxoSmithKline Plc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 ALLERGAN
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Takeda Pharmaceutical Company Limited
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 AstraZeneca
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Astellas Pharma US, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Pfizer Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Gastroenterology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Abbott Laboratories
  • Johnson & Johnson
  • AbbVie Inc.
  • Salix Pharmaceuticals
  • GlaxoSmithKline Plc.
  • ALLERGAN
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Astellas Pharma US Inc.
  • Pfizer Inc.

Methodology

Loading
LOADING...